Brightstar Associates LLC is > 10% Shareholder of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 23.1 Million shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Apr 22, 2024, when has been sold 48,136 shares (Common Stock) at a price of $0.01 per share, resulting in proceeds of $481. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1M
0% 3M change
4.34% 12M change
Total Value Held $0

Brightstar Associates LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 22 2024
BUY
Exercise of in-the-money or at-the-money derivatives securities
$481 $0.01 p/Share
48,136 Added 0.21%
23,107,844 Common Stock
Feb 07 2024
BUY
Exercise of in-the-money or at-the-money derivatives securities
$9,140 $0.01 p/Share
914,001 Added 3.81%
23,059,708 Common Stock
Feb 28 2023
BUY
Exercise of in-the-money or at-the-money derivatives securities
$24,276 $0.01 p/Share
2,427,693 Added 9.88%
22,145,707 Common Stock
Jan 24 2023
BUY
Open market or private purchase
$29,999,988 $18.0 p/Share
1,666,666 Added 7.79%
19,718,014 Common Stock
Apr 29 2022
BUY
Open market or private purchase
$14,789,780 $10.0 p/Share
1,478,978 Added 7.57%
18,051,348 Common Stock
BAL

Brightstar Associates LLC

> 10% Shareholder
Kansas City, MO

Track Institutional and Insider Activities on DCPH

Follow Deciphera Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH